DMS defends use of favipiravir pills

The Department of Medical Services (DMS) on Monday defended the effectiveness of favipiravir in treating Covid-19 patients against an international study claiming the antiviral drug lacked efficacy in treatments.

Related Keywords

Mexico ,United States ,Thailand ,Brazil ,Thai ,Somsak Akksilp ,Department Of Medical Services ,Medical Services ,Covid 19 ,Favipiravir ,Drug ,Pill ,Medicine ,